PETALS: Proteomic Evaluation and Topological Analysis of a mutated Locus' Signaling

Gurkan Bebek1, Vishal Patel, Mark R Chance

  • 1Center for Proteomics and Bioinformatics, Case Western Reserve University, Cleveland, OH 44106, USA. gurkan@case.edu

BMC Bioinformatics
|December 15, 2010
PubMed
Abstract

Insights

Computational methods predict colon cancer pathways. The PETALS pipeline identified a key Apc-Hapln1 pathway, validated by proteomic data, offering insights into cancer driver gene interactions.

Area of Science:

  • Oncology
  • Computational Biology
  • Genomics

Background:

  • Colon cancer is driven by mutations in genes like Apc.
  • Understanding Apc signaling in tumors is complex due to other cancer driver (CAN) gene mutations.
  • Predictive computational methods are needed to identify operative pathways in Apc-mutated tumors.

Purpose of the Study:

  • To develop and apply a computational pipeline (PETALS) for predicting and testing signaling pathways involving Apc and other CAN genes.
  • To identify specific Apc-CAN-gene subnetworks ('petals') within a larger interaction network ('blossom').

Main Methods:

  • Developed the PETALS pipeline to model Apc-CAN-gene interactions.
  • Constructed an Apc interaction network ('blossom') with 24 predicted 'petals'.
  • Utilized a novel bimodality measure to evaluate petal coexpression against proteomic data (2D-DIGE) from Apc¹⁶³⁸(N+/)⁻ mice.

Main Results:

  • The PETALS pipeline identified and prioritized potential signaling pathways.
  • The Apc-Hapln1 pathway demonstrated significant bimodal coexpression with proteomic targets.
  • This suggests the Apc-Hapln1 petal is a key regulator of observed proteome-level effects.

Conclusions:

  • Functional 'omics data can validate in silico predictions of CAN-gene pathways.
  • The study reveals an integrated approach combining genetic models with measured downstream effects.
  • The Apc-Hapln1 pathway is highlighted as a potentially critical player in colon cancer progression.